SR
Satyanarayana Reddy Khairtabad
About Satyanarayana Reddy Khairtabad
Data last updated:
Satyanarayana Reddy Khairtabad is a Managing Director at Arene Life Sciences Private Limited (since 2004), Director at Arene Life Sciences (Unit 3) Private Limited (since 2017) and Whole-Time Director at S.R. Drugs And Intermediates Pvt.Ltd (since 1997), and holds 7 more current directorships. The companies operate in Pharma, Chemicals and Materials and Financial Services. The 5 current companies with reported revenue have a combined latest revenue of ₹903 Cr; the largest is Arene Life Sciences Private Limited at ₹498 Cr (FY 2025). Earlier, Satyanarayana Reddy Khairtabad was a Director at Valentis Laboratories Private Limited (2000–2019) and Director at Srduo Investments Private Limited (from 2020).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Managing Director | 17 Sep 2004 | 2004 | ₹498 Cr (FY 2025) | Active | |
| Director | 02 Sep 2017 | 2006 | ₹288 Cr (FY 2025) | Active | |
| Whole-Time Director | 12 Nov 1997 | 1992 | ₹115 Cr (FY 2025) | Active | |
| Director | 30 Nov 2005 | 1991 | ₹84.7 Lakh (FY 2024) | Active | |
| Director | 05 May 2021 | 2021 | ₹63 Lakh (FY 2022) | Active | |
| Designated Partner | 21 May 2024 | 2024 | Active | ||
| Director | 05 May 2021 | 2021 | Active | ||
| Director | 03 Jun 2020 | 2020 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 01 Apr 2000 | 1999 | ₹161 Cr (FY 2025) | Active | |
| Director | 02 Sep 2020 | 2020 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Satyanarayana Reddy Khairtabad
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Satyanarayana Reddy Khairtabad
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Satyanarayana Reddy Khairtabad
Satyanarayana Reddy Khairtabad currently holds 10 directorships: Arene Life Sciences Private Limited (Managing Director, since 17 Sep 2004, revenue ₹498 Cr (FY 2025)); Arene Life Sciences (Unit 3) Private Limited (Director, since 02 Sep 2017, revenue ₹288 Cr (FY 2025)); S.R. Drugs And Intermediates Pvt.Ltd (Whole-Time Director, since 12 Nov 1997, revenue ₹115 Cr (FY 2025)); M M Fine Grinders Private Limited (Director, since 30 Nov 2005, revenue ₹84.7 Lakh (FY 2024)); S.R. Drugs And Intermediates (Unit 4) Private Limited (Director, since 05 May 2021, revenue ₹63 Lakh (FY 2022)); and 5 more.
Satyanarayana Reddy Khairtabad was first appointed on 12 Nov 1997 as Whole-Time Director at S.R. Drugs And Intermediates Pvt.Ltd. The most recent appointment on record is 21 May 2024 at Satya Sharada Ventures Llp.
The 5 current companies of Satyanarayana Reddy Khairtabad that report revenue have a combined latest revenue of ₹903 Cr: Arene Life Sciences Private Limited ₹498 Cr (FY 2025); Arene Life Sciences (Unit 3) Private Limited ₹288 Cr (FY 2025); S.R. Drugs And Intermediates Pvt.Ltd ₹115 Cr (FY 2025); M M Fine Grinders Private Limited ₹84.7 Lakh (FY 2024); S.R. Drugs And Intermediates (Unit 4) Private Limited ₹63 Lakh (FY 2022).
Satyanarayana Reddy Khairtabad held 2 earlier board appointments: Valentis Laboratories Private Limited (Director, 01 Apr 2000 to 02 Apr 2019); Srduo Investments Private Limited (Director, from 02 Sep 2020).
The current boards of Satyanarayana Reddy Khairtabad's companies include Khairtabad Anuraag Reddy (Arene Life Sciences Private Limited), Prachi Gupta (Arene Life Sciences Private Limited), Santosh Reddy Chinnamail (Arene Life Sciences Private Limited), Satyanarayana Reddy Chinnamail (Arene Life Sciences Private Limited), Satyanarayana Reddy Chinnamail (Arene Life Sciences Private Limited), Nikita Bhandari (Arene Life Sciences (Unit 3) Private Limited), among others.